ubio enters MoU with SCMS Institute of Biosciences for Chikungunya diagnostics
SCMS Institute of Biotechnology and Biosciences (SIBB) has entered into a technical collaboration agreement with ubio Biotechnology Systems Pvt. Ltd. for development and commercialization of medical diagnostics.
- (1888PressRelease) October 05, 2011 - As part of this agreement, ubio will produce and market ELISA, PCR and Rapid lateral flow tests for Chikungunya diagnosis based on technology developed by SIBB.
ubio (www.ubio.in ) is a young, vibrant start-up developing innovative solutions in medical diagnostics. We leverage the latest and best technologies from the fields of electronics, information technology, and biotechnology to create products and solutions that take hi-tech diagnostics to the mass-market. ubio’s vision is Affordable, Accurate, Accessible Diagnostics for All.
SCMS Institute of Bioscience & Biotechnology - Research & Development (SIBB-R&D)(http://www.scmsgroup.org/SIBB/html/01abt.htm ) is a part of SCMS group, with its facility located in Kalamassery, Cochin, focused on high quality research leading to production and patenting of Bioproducts, Recombinant proteins, Industrial enzymes, Transgenic crops, Plant Made Pharmaceuticals [PMP] and Nutraceuticals, in addition to the academic programs in Biotechnology, molecular biology and Tissue engineering.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam